Motion-compensated FDG PET/CT for oesophageal cancer

[1]  S. Heijmink,et al.  Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study , 2018, Clinical and translational radiation oncology.

[2]  Julian C. Hong,et al.  Intratreatment Response Assessment With 18F-FDG PET: Correlation of Semiquantitative PET Features With Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiotherapy. , 2018, International journal of radiation oncology, biology, physics.

[3]  P. V. van Diest,et al.  Rapid on‐site evaluation during endoscopic ultrasoundguided fine‐needle aspiration of lymph nodes does not increase diagnostic yield: A randomized, multicenter trial , 2018, The American Journal of Gastroenterology.

[4]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[5]  A. Scarsbrook,et al.  Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume , 2017, BMC Cancer.

[6]  Habib Zaidi,et al.  Classification and evaluation strategies of auto‐segmentation approaches for PET: Report of AAPM task group No. 211 , 2017, Medical physics.

[7]  G. Nieuwenhuijzen,et al.  Influence of the Extent and Dose of Radiation on Complications After Neoadjuvant Chemoradiation and Subsequent Esophagectomy With Gastric Tube Reconstruction With a Cervical Anastomosis. , 2017, International journal of radiation oncology, biology, physics.

[8]  V. Bettinardi,et al.  Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[9]  Antonio Pontoriero,et al.  Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: Review of the literature. , 2016, Lung cancer.

[10]  Jianbin Li,et al.  Comparative evaluation of CT-based and PET/4DCT-based planning target volumes in the radiation of primary esophageal cancer. , 2015, International journal of clinical and experimental medicine.

[11]  E. Steyerberg,et al.  Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. , 2015, The Lancet. Oncology.

[12]  Daniel T Chang,et al.  Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer. , 2015, International journal of radiation oncology, biology, physics.

[13]  W. Feng,et al.  Safety of dose escalation by simultaneous integrated boosting radiation dose within the primary tumor guided by (18)FDG-PET/CT for esophageal cancer. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Jan-Jakob Sonke,et al.  Differential motion between mediastinal lymph nodes and primary tumor in radically irradiated lung cancer patients. , 2014, International journal of radiation oncology, biology, physics.

[15]  J. V. van Sandick,et al.  Detecting Interval Metastases and Response Assessment Using 18F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Esophageal Cancer , 2014, Clinical nuclear medicine.

[16]  M. V. van Herk,et al.  Registration accuracy and image quality of time averaged mid-position CT scans for liver SBRT. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  M. V. van Herk,et al.  PET motion compensation for radiation therapy using a CT-based mid-position motion model: methodology and clinical evaluation. , 2013, International journal of radiation oncology, biology, physics.

[18]  F Hofheinz,et al.  An automatic method for accurate volume delineation of heterogeneous tumors in PET. , 2012, Medical physics.

[19]  T. Pan,et al.  The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer , 2012, Journal of radiation research.

[20]  Ana María García Vicente,et al.  Value of 4-Dimensional 18F-FDG PET/CT in the Classification of Pulmonary Lesions , 2011, The Journal of Nuclear Medicine Technology.

[21]  C. Hurt,et al.  Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).

[22]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[23]  J. Pruim,et al.  A systematic review on the role of FDG-PET/CT in tumour delineation and radiotherapy planning in patients with esophageal cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  J. Lee,et al.  Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  Habib Zaidi,et al.  PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  Jinming Yu,et al.  Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus. , 2009, International journal of radiation oncology, biology, physics.

[27]  E. Kuipers,et al.  Staging investigations for oesophageal cancer: a meta-analysis , 2008, British Journal of Cancer.

[28]  Radhe Mohan,et al.  Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[29]  Joe Y. Chang,et al.  Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. , 2007, International journal of radiation oncology, biology, physics.

[30]  Helen H Liu,et al.  Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. , 2006, International journal of radiation oncology, biology, physics.

[31]  L. Adler,et al.  The integration of 18-fluoro-deoxy-glucose positron emission tomography and endoscopic ultrasound in the treatment-planning process for esophageal carcinoma. , 2005, International journal of radiation oncology, biology, physics.

[32]  E Yorke,et al.  Four-dimensional (4D) PET/CT imaging of the thorax. , 2004, Medical physics.

[33]  H. Groen,et al.  Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Paul Fockens,et al.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. , 2002, The New England journal of medicine.